---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-002422"
form_type: "8-K"
ticker: null
cik: "0000737207"
company_name: "Adhera Therapeutics, Inc."
filed_at: "2024-01-16T23:59:59+00:00"
generated_at: "2026-06-06T23:36:29.717306+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Adhera Therapeutics CEO and director resign, effective Jan 12, 2024

## Summary
- Trond K. Waerness resigns from Board effective January 12, 2024; no disagreement cited.
- Zahed Subhan resigns as CEO and Board member effective January 12, 2024; no disagreement cited.
- Both departures are not related to company operations, policies, or practices.

## SEC filing metadata
- accession: 0001493152-24-002422
- form_type: 8-K
- cik: 0000737207
- company_name: Adhera Therapeutics, Inc.
- filed_at: 2024-01-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/0001493152-24-002422-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-002422
- JSON: https://secwatch.observer/filing/0001493152-24-002422.json
- Plain text: https://secwatch.observer/filing/0001493152-24-002422.txt

## Key facts
- Executive change
  Zahed Subhan resigned as Chief Executive Officer at Adhera Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: on January 12, 2024, the Company received notice from Zahed Subhan that he was resigning as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/0001493152-24-002422-index.htm
- Executive change
  Trond K. Waerness resigned as Director at Adhera Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: he was resigning from the Company’s Board of Directors effective January 12, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/737207/000149315224002422/0001493152-24-002422-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.